Authors of a recent review outline how non–small-cell lung cancer (NSCLC) management has rapidly evolved through advances in screening, diagnostics, and systemic therapies across early-stage and advanced disease.
Authors of a recent review outline how non–small-cell lung cancer (NSCLC) management has rapidly evolved through advances in screening, diagnostics, and systemic therapies across early-stage and advanced disease.